---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T12:15:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
webUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "4cFc6xF/9PhGOPWiN//gxObUfE2A20GJIrjr6ihVE/83E4rfZu322jEvOzr6Rb+5Cus9IDAPqkxc9lElK7d+7uTt2AwUaPZkWX+rKhHsAVmmO4wv4TM38KHy+o8Es+B7wIsaCSe6uig9l7RxK9lIM7xs/PKc483Ptmrz1lnt5VbYSzDJvOh36Ja2bN8X17kxb+z+37IuKIV0NuKRKfcucDGxFWsazsES5HomO+lOZbnit451/Dp70U1ARBnPWQNe6LK1WARX5qaCu8Q9ywoGvwpyaec9THqlr5IRcGyq4oNwJT7bHQXNTU+7f3+Z9sYuYasw+Ikb/4cHWHImN66cWgnR4KJ3TX1wpXQmOgomIS4=;jfK8cDbNjnDygkrySCOpPQ=="
---

